EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ST32da, a Novel Salvia miltiorrhiza-Derived ATF3 Inducer, Alleviates Obesity-Related Diabetic Nephropathy in Mouse Models

Hsi-Hsien Chen iD, Tzu-Ling Tseng, Hsiao-Fen Li, Ya-Ting Hsieh, Tu Tuan Tran, Yueh-Lin Wu, Heng Lin

Cells · 2025

DOI: 10.3390/cells14231893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Hsi-Hsien Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital, No. 252, Wuxing St., Xinyi Dist., Taipei 110, Taiwan. Hauptthemen laut MEDLINE: Activating Transcription Factor 3, Diabetic Nephropathies, Salvia miltiorrhiza, Obesity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taipei Medical University Hospital, Wan Fang Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is necessary to find novel therapeutic strategies for obesity-related diabetic nephropathy (DN) that target both metabolic dysfunction and renal inflammation. ST32da derived from Salvia miltiorrhiza (a well-recognized Traditional Chinese Medicine) induces activating transcription factor 3 (ATF3), a negative regulator of inflammation and metabolic stress. However, the effects of ST32da on obesity-related DN remain underexplored. We investigated the therapeutic potential of ST32da, a synthetic ATF3 inducer derived from Salvia miltiorrhiza, in mitigating obesity-related DN in both in vivo and in vitro models. The Nephroseq database analysis was performed to explore the relationship between Atf3 expression and DN progression. ST32da was administered to db/db knockout and DBA mice to establish obesity-related DN models, and a high-fat diet (HFD)-induced mouse model of obesity-related DN was used to investigate the effects of Atf3 knockout. Molecular and biochemical analyses were conducted in cultured mesangial cells to elucidate the underlying mechanisms. ATF3 deficiency worsened obesity-related DN, increasing glomerular fibrosis, mortality, and inflammation. ST32da restored ATF3 levels and reduced renal injury, glomerular expansion, and pro-inflammatory cytokine expression (e.g., IL-6, TGFβ, TNFα). ST32da-treated mice exhibited reduced hepatic lipid accumulation and improved serum lipid profiles. In mesangial cells, ST32da localized to the cytoplasm and increased ATF3 activity, which suppressed RARRES1 expression and cytokine signaling. Mechanistically, ATF3 interacted with HDAC2 to repress NF-κB—dependent inflammatory gene expression. The findings suggest ST32da is a promising therapeutic candidate for obesity-related DN and associated metabolic disturbances, acting through ATF3 induction to suppress renal inflammation, lipotoxicity, and fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activating Transcription Factor 3Diabetic NephropathiesSalvia miltiorrhizaObesityAnimalsMiceDisease Models, AnimalMaleDiet, High-FatMice, KnockoutMice, Inbred C57BLInflammationMesangial Cells

Stichwörter der Autor:innen

ATF3HDAC2ST32dadiabetic nephropathylipotoxicityrenal inflammation

Substanzen

Activating Transcription Factor 3Atf3 protein, mouse

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital, No. 252, Wuxing St., Xinyi Dist., Taipei 110, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wuxing St., Xinyi Dist., Taipei 110, Taiwan.
  • TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei 110, Taiwan.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei Medical University Hospital, No. 252, Wuxing St., Xinyi Dist., Taipei 110, Taiwan.
  • CardioVascular Research Center, Buddhist Tzu Chi General Hospital, No. 707, Zhongyang Rd., Sec. 3, Hualien 97004, Taiwan.
  • Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan.

ORCID-Profile: Hsi-Hsien Chen

Förderung

  • National Science and Technology Council
  • Taipei Medical University Hospital
  • Wan Fang Hospital
  • Taipei Medical University
  • Ministry of Science and Technology
  • Taipei Medical University, Taipei Medical University Hospital

Zitieren

APA

Chen, H. H., Tseng, T. L., Li, H. F., Hsieh, Y. T., Tran, T. T., Wu, Y. L., & Lin, H. (2025). ST32da, a Novel Salvia miltiorrhiza-Derived ATF3 Inducer, Alleviates Obesity-Related Diabetic Nephropathy in Mouse Models. Cells. https://doi.org/10.3390/cells14231893

Vancouver

Chen HH, Tseng TL, Li HF, Hsieh YT, Tran TT, Wu YL, et al. ST32da, a Novel Salvia miltiorrhiza-Derived ATF3 Inducer, Alleviates Obesity-Related Diabetic Nephropathy in Mouse Models. Cells. 2025. doi:10.3390/cells14231893

BibTeX
@article{Chen2025,
  author = {Chen, Hsi-Hsien and Tseng, Tzu-Ling and Li, Hsiao-Fen and Hsieh, Ya-Ting and Tran, Tu Tuan and Wu, Yueh-Lin and Lin, Heng},
  title = {ST32da, a Novel Salvia miltiorrhiza-Derived ATF3 Inducer, Alleviates Obesity-Related Diabetic Nephropathy in Mouse Models},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14231893}
}
Kostenlos starten →